Shares are up 13% in pre-market and more than 8,290 shares have gone off on more than 5.7 million in volume. The stock is at .23 and the VWAP is closer to .27. The stock is well off it’s recent high of .55
First Wave BioPharma, Inc. Announces Closing of $9 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules